SureTrader
Home > Boards > US Listed > Biotechs > Ariad Pharmaceuticals, Inc. (ARIA)

That would be logical once the anecdotal reports

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
vidpok45 Member Profile
 
Followed By 20
Posts 3,508
Boards Moderated 0
Alias Born 06/15/10
160x600 placeholder
Advertisement
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 6/25/2015 4:08:06 PM
ARIAD rende noti i dati sulla sicurezza e l'efficacia a lungo termine di Ponatinib ottenuti da uno studio clinico Pace di fas... "Business Wire" - 6/17/2015 7:17:00 PM
ARIAD met à jour les données de tolérance et d'efficacité à long terme du ponatinib,provenant de l'essai clinique de pha... "Business Wire" - 6/16/2015 12:34:00 PM
ARIAD legt langfristige Sicherheits- und Wirksamkeitsdaten zu Ponatinib aus klinischer Phase-2-Studie PACE vor "Business Wire" - 6/14/2015 8:53:00 AM
ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial "Business Wire" - 6/12/2015 11:15:00 AM
Cancer Stocks: 2 to Sell, 1 to Buy "The Motley Fool" - 6/10/2015 10:05:06 AM
ARIAD and Paladin Announce Commercial Distribution Agreement for Iclusig (Ponatinib) in Canada "Business Wire" - 6/10/2015 7:35:00 AM
ARIAD Et Laboratoires Paladin Annoncent La Signature D’une Entente De Distribution Commerciale D’iclusig (Ponatinib) Au C... "Business Wire" - 6/10/2015 7:35:00 AM
ARIAD to Present at the Goldman Sachs Annual Global Healthcare Conference "Business Wire" - 6/8/2015 7:35:00 AM
ARIAD Presents Updated Clinical Data on brigatinib in Patients with ALK+ Non-Small Cell Lung Cancer at the 2015 ASCO Meeting "Business Wire" - 6/1/2015 9:00:00 AM
ARIAD Announces Long-Term Safety & Efficacy Data Of Ponatinib in Chronic-Phase Chronic Myeloid Leukemia from Phase 1 Clinical... "Business Wire" - 5/31/2015 9:00:00 AM
ARIAD meldet Datenpräsentationen auf dem Kongress der Europäischen Gesellschaft für Hämatologie (EHA) "Business Wire" - 5/22/2015 10:59:00 AM
ARIAD Announces Data Presentations at the European Hematology Association (EHA) Congress "Business Wire" - 5/22/2015 7:35:00 AM
ARIAD to Present at the Jefferies 2015 Global Healthcare Conference "Business Wire" - 5/21/2015 7:35:00 AM
ARIAD Announces Data Presentations at the 2015 ASCO Annual Meeting "Business Wire" - 5/14/2015 7:35:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/8/2015 5:36:06 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/7/2015 7:46:04 AM
ARIAD Reports First Quarter 2015 Financial Results and Progress on Strategic Objectives "Business Wire" - 5/7/2015 7:35:00 AM
ARIAD Announces Commercial Distribution Agreement for Iclusig (ponatinib) in Turkey "Business Wire" - 5/6/2015 7:35:00 AM
Ariad Pharmaceuticals Upgraded by Vetr Inc. to Buy (ARIA) "Analyst Ratings Network" - 5/5/2015 8:12:47 PM
Is This Why the Street Keeps Doubting Gilead Sciences, Inc.? "The Motley Fool" - 5/5/2015 8:11:03 AM
Vetr Inc. Lowers Ariad Pharmaceuticals to Hold (ARIA) "Analyst Ratings Network" - 5/4/2015 8:10:22 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/4/2015 4:38:15 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/30/2015 5:14:04 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist